Novel Nuclear Nesprin-2 Variants Tether Active Extracellular Signal-regulated MAPK1 and MAPK2 at Promyelocytic Leukemia Protein Nuclear Bodies and Act to Regulate Smooth Muscle Cell Proliferation

Derek Warren, Tamara Tajsic, Jason A. Mellad, Richelle G. Searles, Qiuping Zhang, Catherine M. Shanahan

Journal of Biological Chemistry · 2009 · 57 citations · 26 references

DOIFull text

Open access

Concepts

Abstract

Nuclear and cytoplasmic scaffold proteins have been shown to be essential for temporal and spatial organization, as well as the fidelity, of MAPK signaling pathways. In this study we show that nesprin-2 is a novel extracellular signal-regulated MAPK1 and 2 (ERK1/2) scaffold protein that serves to regulate nuclear signaling by tethering these kinases at promyelocytic leukemia protein nuclear bodies (PML NBs). Using immunofluorescence microscopy, GST pull-down and immunoprecipitation, we show that nesprin-2, ERK1/2, and PML colocalize and bind to form a nuclear complex. Interference of nesprin-2 function, by either siRNA-mediated knockdown or overexpression of a dominant negative nesprin-2 fragment, augmented ERK1/2 nuclear signaling shown by increased SP1 activity and ELK1 phosphorylation. The functional outcome of nesprin-2 disruption and the resultant sustained ERK1/2 signal was increased proliferation. Importantly, these activities were not induced by previously identified nuclear envelope (NE)-targeted nesprin-2 isoforms but rather were mediated by novel nuclear isoforms that lacked the KASH domain. Taken together, this study suggests that nesprin-2 is a novel intranuclear scaffold, essential for nuclear ERK1/2 signaling fidelity and cell cycle progression. Nuclear and cytoplasmic scaffold proteins have been shown to be essential for temporal and spatial organization, as well as the fidelity, of MAPK signaling pathways. In this study we show that nesprin-2 is a novel extracellular signal-regulated MAPK1 and 2 (ERK1/2) scaffold protein that serves to regulate nuclear signaling by tethering these kinases at promyelocytic leukemia protein nuclear bodies (PML NBs). Using immunofluorescence microscopy, GST pull-down and immunoprecipitation, we show that nesprin-2, ERK1/2, and PML colocalize and bind to form a nuclear complex. Interference of nesprin-2 function, by either siRNA-mediated knockdown or overexpression of a dominant negative nesprin-2 fragment, augmented ERK1/2 nuclear signaling shown by increased SP1 activity and ELK1 phosphorylation. The functional outcome of nesprin-2 disruption and the resultant sustained ERK1/2 signal was increased proliferation. Importantly, these activities were not induced by previously identified nuclear envelope (NE)-targeted nesprin-2 isoforms but rather were mediated by novel nuclear isoforms that lacked the KASH domain. Taken together, this study suggests that nesprin-2 is a novel intranuclear scaffold, essential for nuclear ERK1/2 signaling fidelity and cell cycle progression. IntroductionMitogen-activated protein kinase (MAPK) 2The abbreviations used are: MAPKmitogen-activated protein kinaseERKextracellular signal-regulated kinaseUTRuntranslated regionIFimmunofluorescenceVSMCvascular smooth muscle cellsESTexpressed sequence tagNEnuclear envelopePMLpromyelocytic leukemia proteinNBnuclear bodiesINMinner nuclear membraneONMouter nuclear membraneGSTglutathione S-transferaseWBWestern blotELISAenzyme-linked immunosorbent assayKASHKlarsicht, ANC-1, Syne homology domain. signaling has essential roles in proliferation, differentiation, and apoptosis (1Chambard J.C. Lefloch R. Pouysségur J. Lenormand P. Biochim. Biophys. Acta. 2007; 1773: 1299-1310Crossref PubMed Scopus (551) Google Scholar, 2Shaul Y.D. Seger R. Biochim Biophys Acta. 2007; 1773: 1213-1226Crossref PubMed Scopus (684) Google Scholar, 3Yoon S. Seger R. Growth Factors. 2006; 24: 21-44Crossref PubMed Google Scholar). The extracellular signal-regulated MAPK1 and MAPK2 (ERK1/2) are the best characterized MAPK members. In response to extracellular stimuli, ERK1/2 becomes phosphorylated via the RAS signaling pathway and active ERK1/2 translocates from the cytoplasm to the nucleus (3Yoon S. Seger R. Growth Factors. 2006; 24: 21-44Crossref PubMed Google Scholar, 4Pouysségur J. Lenormand P. Eur. J. Biochem. 2003; 270: 3291-3299Crossref PubMed Scopus (154) Google Scholar, 5Pouysségur J. Volmat V. Lenormand P. Biochem. Pharmacol. 2002; 64: 755-763Crossref PubMed Scopus (359) Google Scholar) to regulate transcription and cell cycle progression (1Chambard J.C. Lefloch R. Pouysségur J. Lenormand P. Biochim. Biophys. Acta. 2007; 1773: 1299-1310Crossref PubMed Scopus (551) Google Scholar, 7Meloche S. Pouysségur J. Oncogene. 2007; 26: 3227-3239Crossref PubMed Scopus (835) Google Scholar, 8Pagès G. Lenormand P. L'Allemain G. Chambard J.C. Meloche S. Pouysségur J. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 8319-8323Crossref PubMed Scopus (923) Google Scholar). Recently, studies have highlighted the importance of ERK1/2 scaffold proteins in determining the duration of signaling within the nucleus. ERK1/2 diffuses across the nuclear membrane, with movement in and out of the nucleus determined by both cytoplasmic and nuclear ERK1/2-binding partners (9Burack W.R. Shaw A.S. J. Biol. Chem. 2005; 280: 3832-3837Abstract Full Text Full Text PDF PubMed Scopus (87) Google Scholar, 10Costa M. Marchi M. Cardarelli F. Roy A. Beltram F. Maffei L. Ratto G.M. J. Cell Sci. 2006; 119: 4952-4963Crossref PubMed Scopus (78) Google Scholar). Its diffusion is further impeded by phosphorylation, suggesting that active ERK1/2 forms large complexes of low mobility within nuclei (10Costa M. Marchi M. Cardarelli F. Roy A. Beltram F. Maffei L. Ratto G.M. J. Cell Sci. 2006; 119: 4952-4963Crossref PubMed Scopus (78) Google Scholar). However the precise localization and components of these complexes remain unknown.Nesprins are a novel family of spectrin repeat-containing proteins that were originally identified from a differential cDNA screen as highly expressed in differentiated vascular smooth muscle cells (VSMCs) (11Zhang Q. Skepper J.N. Yang F. Davies J.D. Hegyi L. Roberts R.G. Weissberg P.L. Ellis J.A. Shanahan C.M. J. Cell Sci. 2001; 114: 4485-4498Crossref PubMed Google Scholar, 12Apel E.D. Lewis R.M. Grady R.M. Sanes J.R. J. Biol. Chem. 2000; 275: 31986-31995Abstract Full Text Full Text PDF PubMed Scopus (225) Google Scholar). To date, four nesprin genes have been identified that encode a plethora of variants that vary greatly in size. The largest, or giant variants of nesprin-1 and nesprin-2 consist of an N-terminal-paired calponin homology domain, a central rod domain comprised of multiple spectrin repeats, and a C-terminal Klarsicht, ANC-1, Syne Homology (KASH) domain required for NE localization (11Zhang Q. Skepper J.N. Yang F. Davies J.D. Hegyi L. Roberts R.G. Weissberg P.L. Ellis J.A. Shanahan C.M. J. Cell Sci. 2001; 114: 4485-4498Crossref PubMed Google Scholar, 12Apel E.D. Lewis R.M. Grady R.M. Sanes J.R. J. Biol. Chem. 2000; 275: 31986-31995Abstract Full Text Full Text PDF PubMed Scopus (225) Google Scholar, 13Padmakumar V.C. Libotte T. Lu W. Zaim H. Abraham S. Noegel A.A. Gotzmann J. Foisner R. Karakesisoglou I. J. Cell Sci. 2005; 118: 3419-3430Crossref PubMed Scopus (323) Google Scholar). Initially, nesprins were described as components of the inner nuclear membrane (INM) where they interact with lamins A/C and emerin (14Zhang Q. Ragnauth C.D. Skepper J.N. Worth N.F. Warren D.T. Roberts R.G. Weissberg P.L. Ellis J.A. Shanahan C.M. J. Cell Sci. 2005; 118: 673-687Crossref PubMed Scopus (213) Google Scholar, 15Wheeler M.A. Davies J.D. Zhang Q. Emerson L.J. Hunt J. Shanahan C.M. Ellis J.A. Exp. Cell Res. 2007; 313: 2845-2857Crossref PubMed Scopus (70) Google Scholar, 16Mislow J.M. Holaska J.M. Kim M.S. Lee K.K. Segura-Totten M. Wilson K.L. McNally E.M. FEBS Lett. 2002; 525: 135-140Crossref PubMed Scopus (215) Google Scholar, 17Libotte T. Zaim H. Abraham S. Padmakumar V.C. Schneider M. Lu W. Munck M. Hutchison C. Wehnert M. Fahrenkrog B. Sauder U. Aebi U. Noegel A.A. Karakesisoglou I. Mol. Biol. Cell. 2005; 16: 3411-3424Crossref PubMed Scopus (139) Google Scholar). In conjunction with larger, actin-binding outer nuclear membrane (ONM) nesprin isoforms, INM nesprins function to link the nuclear lamina to cytoplasmic cytoskeletal structures via association with SUN domain-containing proteins (18Starr D.A. Han M. Science. 2002; 298: 406-409Crossref PubMed Scopus (317) Google Scholar, 19Starr D.A. Han M. J. Cell Sci. 2003; 116: 211-216Crossref PubMed Scopus (197) Google Scholar, 20Wilhelmsen K. Ketema M. Truong H. Sonnenberg A. J. Cell Sci. 2006; 119: 5021-5029Crossref PubMed Scopus (106) Google Scholar, 21Haque F. Lloyd D.J. Smallwood D.T. Dent C.L. Shanahan C.M. Fry A.M. Trembath R.C. Shackleton S. Mol. Cell. Biol. 2006; 26: 3738-3751Crossref PubMed Scopus (367) Google Scholar). However, studies using antibodies generated to peptides along the length of the giant nesprin proteins, have shown that nesprins are also present in other cytoplasmic and nuclear structures (14Zhang Q. Ragnauth C.D. Skepper J.N. Worth N.F. Warren D.T. Roberts R.G. Weissberg P.L. Ellis J.A. Shanahan C.M. J. Cell Sci. 2005; 118: 673-687Crossref PubMed Scopus (213) Google Scholar, 23Zhen Y.Y. Libotte T. Munck M. Noegel A.A. Korenbaum E. J. Cell Sci. 2002; 115: 3207-3222Crossref PubMed Google Scholar, 24Padmakumar V.C. Abraham S. Braune S. Noegel A.A. Tunggal B. Karakesisoglou I. Korenbaum E. Exp. Cell Res. 2004; 295: 330-339Crossref PubMed Scopus (166) Google Scholar). Our understanding of the role of nesprins within these other subcellular compartments remains to be elucidated and to date, very few nesprin interaction partners have been described. Therefore, we set out to identify novel nesprin-2-binding partners as a means to interrogate further the functions of nesprin-2. We identified ERK1/2 and PML as nesprin-2 interaction partners and demonstrate that nesprin-2 acts to scaffold ERK2 within the nucleus at promyelocytic leukemia protein nuclear bodies (PML NBs), where this complex serves to inhibit ERK1/2 activity. Thus nesprin-2 plays fundamental roles in regulating nuclear ERK1/2 signaling events and is essential for normal cell cycle progression.DISCUSSIONIn this study, we identify nesprin-2 as a nuclear scaffold and ERK1/2 and PML as novel nesprin-2-interacting proteins. These proteins colocalize and form a complex at PML NBs that block ERK1/2-mediated signaling within the nucleus. Disruption of nesprin-2 function by siRNA-mediated knockdown or overexpression, uncoupled ERK1/2 from PML NBs, augmented nuclear ERK1/2 signaling and ultimately induced cell proliferation. This is the first study to describe an ERK1/2 scaffold that tethers these kinases to a specific subnuclear compartment and suggests that nesprin-2 functions to fine-tune ERK-initiated proliferation in multiple cell types. As such it is likely to be a novel target for modifying the function of these kinases in hyperproliferative disorders such as restenosis.Novel Nesprin-2 Variants Tether ERK1/2 at PML NBsThis study demonstrates for the first time that nesprin-2 plays essential roles within the nucleus. By forming a complex with ERK1/2 and PML, nesprin-2 regulates nuclear signaling events by sequestering active ERK1/2 at PML NBs away from its nuclear targets. The 75-kDa nesprin-2 isoform precipitated by both PML and ERK2 antibodies was present in multiple cell types, implying that nesprin-2 function is highly conserved and that tethering of ERK1/2 at PML NBs is a common mechanism for regulating nuclear activity of these kinases. Disruption of nesprin-2 function, by either siRNA-mediated knockdown or overexpression of a dominant negative fragment, that failed to localize correctly to PML NBs, increased nuclear ERK1/2 activity. Importantly, nesprin-2 knockdown did not disrupt the INM, shown by emerin localization, whereas overexpression of a large nesprin-2 fragment predicted to localize to the ONM, did not affect ERK1/2 activity, confirming that this novel ERK1/2 scaffolding function of nesprin-2 is independent of the previously described NE roles of nesprin-2.PML exists in multiple isoforms that reside in both the cytoplasm and nucleus. Our data demonstrate that nesprin-2 associates with a 50-kDa PML isoform corresponding to the approximate size of PML VIIb (27Reymond A. Meroni G. Fantozzi A. Merla G. Cairo S. Luzi L. Riganelli D. Zanaria E. Messali S. Cainarca S. Guffanti A. Minucci S. Pelicci P.G. Ballabio A. EMBO J. 2001; 20: 2140-2151Crossref PubMed Scopus (1030) Google Scholar, 28Jensen K. Shiels C. Freemont P.S. Oncogene. 2001; 20: 7223-7233Crossref PubMed Scopus (377) Google Scholar). This PML isoform is truncated within the C terminus and lacks the NLS utilized by larger PML isoforms (28Jensen K. Shiels C. Freemont P.S. Oncogene. 2001; 20: 7223-7233Crossref PubMed Scopus (377) Google Scholar). Interestingly, this isoform is the predominant PML isoform in VSMC lysates and is localized within PML NBs, suggesting that this isoform can enter the nucleus without the NLS and can efficiently incorporate into nuclear bodies.The binding site for ERK1/2 and PML in nesprin-2 occurs within a highly spliced region of the gene. Previous studies have highlighted the multi-isomeric nature of nesprin proteins (11Zhang Q. Skepper J.N. Yang F. Davies J.D. Hegyi L. Roberts R.G. Weissberg P.L. Ellis J.A. Shanahan C.M. J. Cell Sci. 2001; 114: 4485-4498Crossref PubMed Google Scholar, 14Zhang Q. Ragnauth C.D. Skepper J.N. Worth N.F. Warren D.T. Roberts R.G. Weissberg P.L. Ellis J.A. Shanahan C.M. J. Cell Sci. 2005; 118: 673-687Crossref PubMed Scopus (213) Google Scholar, 29Warren D.T. Zhang Q. Weissberg P.L. Shanahan C.M. Exp. Rev. Mol. Med. 2005; 7: 1-15Crossref PubMed Scopus (95) Google Scholar), and in this study, using EST data base searching and PCR verification, we identified multiple novel nesprin-2 variants containing the ERK/PML binding domain. The predicted sizes of these variants were between 79 and 377 kDa, which corresponded to the size range of the nesprin-2 variants detected by WB, using the N3 antibody that recognizes an epitope very near the ERK/PML binding domain. Some of these isoforms, including those lacking the KASH domain, were predicted to be in the order of 75 kDa, the size of the nesprin-2 variant that interacts with ERK1/2 and PML. Indeed, the previously described nesprin-2βΔTM fused to a FLAG tag localized at PML NBs, suggesting that this variant scaffolds ERK1/2 at PML NBs. Although our siRNAs also depleted variants of 160 and 100 kDa, this depletion was only partial, and these did not interact with ERK1/2, further supporting nesprin-2βΔTM as the variant of interest.Nesprin-2 Regulates ERK1/2 Activity to Regulate Cell ProliferationNesprin-2 is the first ERK1/2 scaffold that allows compartmentalization of these kinases at specific nuclear subdomains. Subnuclear targeting is essential for both the spatial and temporal regulation of these kinases and differential subnuclear localization may explain variations observed in cellular response to ERK1/2 signaling between different cell types. Indeed, nesprin-2 depletion augmented ERK1/2 activity and increased VSMC proliferation, suggesting that tethering ERK1/2 at PML NBs delays cell cycle progression. The ability to pause within the cell cycle is essential for cells to maintain cell cycle fidelity. We hypothesize that the formation of this complex allows temporary inhibition of ERK1/2 nuclear signaling, without dephosphorylating these kinases, allowing cells to inhibit ERK1/2 activity yet maintain a pool of active ERK1/2 within the nucleus. This may be essential for rapid, transient regulation of these kinases within the nucleus, allowing cells to tightly control transcription factor activation by rapidly inducing cycles of assembly/disassembly of this complex.Importantly, cells also need to delay the cell cycle upon differentiation and we observed that this complex appeared to be more stable in slow growing, more differentiated VSMCs that displayed prominent contractile actin filaments (data not shown). In the vessel wall VSMCs exist in a contractile, differentiated state but are not terminally differentiated and retain the ability to dedifferentiate into a non-contractile, proliferative cell in response to stimuli, to in This of VSMCs may explain they prominent nesprin-2 and ERK1/2 at PML NBs. ERK1/2 activity has been shown to VSMC in both and with inhibition of these kinases differentiation and proliferation Zhang K. J. Cell. Biochem. 2006; PubMed Scopus Google Scholar, K. A. PubMed Scopus Google Scholar, R. W. M. 2002; PubMed Scopus Google Scholar, W. Cell Res. 2002; PubMed Scopus Google Scholar). VSMCs this complex to and active ERK1/2 in the nucleus differentiation allowing contractile cells to be to upon to the However, the that regulate and roles for the complex in this further In the and other that the assembly/disassembly of this complex remain to be for Nesprin-2 in PML NBs to the Nuclear of NE is nuclear PML NBs are and Importantly, the ERK1/2 and PML binding are of a region identified in suggesting that these binding are present in suggests that the 75-kDa variant identified in this study both Indeed, only nesprin-2 containing the A/C binding region efficiently within the nucleus suggesting that nuclear lamina may be essential for the nuclear of nesprin-2. In we previously that the nesprin-2 N3 used in this study, can efficiently lamins A/C both in and in (11Zhang Q. Skepper J.N. Yang F. Davies J.D. Hegyi L. Roberts R.G. Weissberg P.L. Ellis J.A. Shanahan C.M. J. Cell Sci. 2001; 114: 4485-4498Crossref PubMed Google Q. Ragnauth C.D. Skepper J.N. Worth N.F. Warren D.T. Roberts R.G. Weissberg P.L. Ellis J.A. Shanahan C.M. J. Cell Sci. 2005; 118: 673-687Crossref PubMed Scopus (213) Google J.M. Holaska J.M. Kim M.S. Lee K.K. Segura-Totten M. Wilson K.L. McNally E.M. FEBS Lett. 2002; 525: 135-140Crossref PubMed Scopus (215) Google Scholar). The lamins in are likely to be the intranuclear lamins as the lamins A/C be further suggesting that nesprin-2 forms studies have essential roles for the nuclear lamina in signaling proteins. The and nuclear localization of protein in nuclear is the of the nuclear lamina and its disruption in cells lacking lamins A/C proliferation T. M. K. H. S. Oncogene. Google Scholar, E. T. Foisner R. Hutchison Mol. Biol. Cell. 2002; PubMed Scopus Google Scholar, L. D.A. C.L. E. Proc. Natl. Acad. Sci. U.S.A. 2004; PubMed Scopus Google Scholar, V. J. B. M. T. Foisner R. Hutchison C. E. J. Cell Biol. 2007; PubMed Scopus Google Scholar, M.A. B. J.A. S. Lee Proc. Natl. Acad. Sci. U.S.A. PubMed Scopus Google Scholar). nesprin-2 may between lamins A/C and PML NBs with this spatial for the of nuclear lamina disruption may upon the complex also these proteins in the highly complex with that of in lamins A/C and its including nesprin-2 Q. C. Worth N.F. Davies J.D. C. A. Ragnauth C.D. Q. J.A. Warren D.T. M.A. Ellis J.A. Skepper J.N. M. B. Weissberg P.L. Roberts R.G. Wehnert M. Shanahan C.M. 2007; 16: PubMed Scopus Google Scholar). IntroductionMitogen-activated protein kinase (MAPK) 2The abbreviations used are: MAPKmitogen-activated protein kinaseERKextracellular signal-regulated kinaseUTRuntranslated regionIFimmunofluorescenceVSMCvascular smooth muscle cellsESTexpressed sequence tagNEnuclear envelopePMLpromyelocytic leukemia proteinNBnuclear bodiesINMinner nuclear membraneONMouter nuclear membraneGSTglutathione S-transferaseWBWestern blotELISAenzyme-linked immunosorbent assayKASHKlarsicht, ANC-1, Syne homology domain. signaling has essential roles in proliferation, differentiation, and apoptosis (1Chambard J.C. Lefloch R. Pouysségur J. Lenormand P. Biochim. Biophys. Acta. 2007; 1773: 1299-1310Crossref PubMed Scopus (551) Google Scholar, 2Shaul Y.D. Seger R. Biochim Biophys Acta. 2007; 1773: 1213-1226Crossref PubMed Scopus (684) Google Scholar, 3Yoon S. Seger R. Growth Factors. 2006; 24: 21-44Crossref PubMed Google Scholar). The extracellular signal-regulated MAPK1 and MAPK2 (ERK1/2) are the best characterized MAPK members. In response to extracellular stimuli, ERK1/2 becomes phosphorylated via the RAS signaling pathway and active ERK1/2 translocates from the cytoplasm to the nucleus (3Yoon S. Seger R. Growth Factors. 2006; 24: 21-44Crossref PubMed Google Scholar, 4Pouysségur J. Lenormand P. Eur. J. Biochem. 2003; 270: 3291-3299Crossref PubMed Scopus (154) Google Scholar, 5Pouysségur J. Volmat V. Lenormand P. Biochem. Pharmacol. 2002; 64: 755-763Crossref PubMed Scopus (359) Google Scholar) to regulate transcription and cell cycle progression (1Chambard J.C. Lefloch R. Pouysségur J. Lenormand P. Biochim. Biophys. Acta. 2007; 1773: 1299-1310Crossref PubMed Scopus (551) Google Scholar, 7Meloche S. Pouysségur J. Oncogene. 2007; 26: 3227-3239Crossref PubMed Scopus (835) Google Scholar, 8Pagès G. Lenormand P. L'Allemain G. Chambard J.C. Meloche S. Pouysségur J. Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 8319-8323Crossref PubMed Scopus (923) Google Scholar). Recently, studies have highlighted the importance of ERK1/2 scaffold proteins in determining the duration of signaling within the nucleus. ERK1/2 diffuses across the nuclear membrane, with movement in and out of the nucleus determined by both cytoplasmic and nuclear ERK1/2-binding partners (9Burack W.R. Shaw A.S. J. Biol. Chem. 2005; 280: 3832-3837Abstract Full Text Full Text PDF PubMed Scopus (87) Google Scholar, 10Costa M. Marchi M. Cardarelli F. Roy A. Beltram F. Maffei L. Ratto G.M. J. Cell Sci. 2006; 119: 4952-4963Crossref PubMed Scopus (78) Google Scholar). Its diffusion is further impeded by phosphorylation, suggesting that active ERK1/2 forms large complexes of low mobility within nuclei (10Costa M. Marchi M. Cardarelli F. Roy A. Beltram F. Maffei L. Ratto G.M. J. Cell Sci. 2006; 119: 4952-4963Crossref PubMed Scopus (78) Google Scholar). However the precise localization and components of these complexes remain unknown.Nesprins are a novel family of spectrin repeat-containing proteins that were originally identified from a differential cDNA screen as highly expressed in differentiated vascular smooth muscle cells (VSMCs) (11Zhang Q. Skepper J.N. Yang F. Davies J.D. Hegyi L. Roberts R.G. Weissberg P.L. Ellis J.A. Shanahan C.M. J. Cell Sci. 2001; 114: 4485-4498Crossref PubMed Google Scholar, 12Apel E.D. Lewis R.M. Grady R.M. Sanes J.R. J. Biol. Chem. 2000; 275: 31986-31995Abstract Full Text Full Text PDF PubMed Scopus (225) Google Scholar). To date, four nesprin genes have been identified that encode a plethora of variants that vary greatly in size. The largest, or giant variants of nesprin-1 and nesprin-2 consist of an N-terminal-paired calponin homology domain, a central rod domain comprised of multiple spectrin repeats, and a C-terminal Klarsicht, ANC-1, Syne Homology (KASH) domain required for NE localization (11Zhang Q. Skepper J.N. Yang F. Davies J.D. Hegyi L. Roberts R.G. Weissberg P.L. Ellis J.A. Shanahan C.M. J. Cell Sci. 2001; 114: 4485-4498Crossref PubMed Google Scholar, 12Apel E.D. Lewis R.M. Grady R.M. Sanes J.R. J. Biol. Chem. 2000; 275: 31986-31995Abstract Full Text Full Text PDF PubMed Scopus (225) Google Scholar, 13Padmakumar V.C. Libotte T. Lu W. Zaim H. Abraham S. Noegel A.A. Gotzmann J. Foisner R. Karakesisoglou I. J. Cell Sci. 2005; 118: 3419-3430Crossref PubMed Scopus (323) Google Scholar). Initially, nesprins were described as components of the inner nuclear membrane (INM) where they interact with lamins A/C and emerin (14Zhang Q. Ragnauth C.D. Skepper J.N. Worth N.F. Warren D.T. Roberts R.G. Weissberg P.L. Ellis J.A. Shanahan C.M. J. Cell Sci. 2005; 118: 673-687Crossref PubMed Scopus (213) Google Scholar, 15Wheeler M.A. Davies J.D. Zhang Q. Emerson L.J. Hunt J. Shanahan C.M. Ellis J.A. Exp. Cell Res. 2007; 313: 2845-2857Crossref PubMed Scopus (70) Google Scholar, 16Mislow J.M. Holaska J.M. Kim M.S. Lee K.K. Segura-Totten M. Wilson K.L. McNally E.M. FEBS Lett. 2002; 525: 135-140Crossref PubMed Scopus (215) Google Scholar, 17Libotte T. Zaim H. Abraham S. Padmakumar V.C. Schneider M. Lu W. Munck M. Hutchison C. Wehnert M. Fahrenkrog B. Sauder U. Aebi U. Noegel A.A. Karakesisoglou I. Mol. Biol. Cell. 2005; 16: 3411-3424Crossref PubMed Scopus (139) Google Scholar). In conjunction with larger, actin-binding outer nuclear membrane (ONM) nesprin isoforms, INM nesprins function to link the nuclear lamina to cytoplasmic cytoskeletal structures via association with SUN domain-containing proteins (18Starr D.A. Han M. Science. 2002; 298: 406-409Crossref PubMed Scopus (317) Google Scholar, 19Starr D.A. Han M. J. Cell Sci. 2003; 116: 211-216Crossref PubMed Scopus (197) Google Scholar, 20Wilhelmsen K. Ketema M. Truong H. Sonnenberg A. J. Cell Sci. 2006; 119: 5021-5029Crossref PubMed Scopus (106) Google Scholar, 21Haque F. Lloyd D.J. Smallwood D.T. Dent C.L. Shanahan C.M. Fry A.M. Trembath R.C. Shackleton S. Mol. Cell. Biol. 2006; 26: 3738-3751Crossref PubMed Scopus (367) Google Scholar). However, studies using antibodies generated to peptides along the length of the giant nesprin proteins, have shown that nesprins are also present in other cytoplasmic and nuclear structures (14Zhang Q. Ragnauth C.D. Skepper J.N. Worth N.F. Warren D.T. Roberts R.G. Weissberg P.L. Ellis J.A. Shanahan C.M. J. Cell Sci. 2005; 118: 673-687Crossref PubMed Scopus (213) Google Scholar, 23Zhen Y.Y. Libotte T. Munck M. Noegel A.A. Korenbaum E. J. Cell Sci. 2002; 115: 3207-3222Crossref PubMed Google Scholar, 24Padmakumar V.C. Abraham S. Braune S. Noegel A.A. Tunggal B. Karakesisoglou I. Korenbaum E. Exp. Cell Res. 2004; 295: 330-339Crossref PubMed Scopus (166) Google Scholar). Our understanding of the role of nesprins within these other subcellular compartments remains to be elucidated and to date, very few nesprin interaction partners have been described. Therefore, we set out to identify novel nesprin-2-binding partners as a means to interrogate further the functions of nesprin-2. We identified ERK1/2 and PML as nesprin-2 interaction partners and demonstrate that nesprin-2 acts to scaffold ERK2 within the nucleus at promyelocytic leukemia protein nuclear bodies (PML NBs), where this complex serves to inhibit ERK1/2 activity. Thus nesprin-2 plays fundamental roles in regulating nuclear ERK1/2 signaling events and is essential for normal cell cycle progression.

References

26